Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment
- Status
- COMPLETED
- Phase
- PHASE1
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)
- Status
- COMPLETED
- Phase
- PHASE2
Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
- Status
- COMPLETED
- Phase
- PHASE2
Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Hodgkin's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease
- Status
- TERMINATED
- Phase
- PHASE3
S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2